Literature DB >> 9312147

Interactions between brain-derived neurotrophic factor and the TRKB receptor. Identification of two ligand binding domains in soluble TRKB by affinity separation and chemical cross-linking.

M Haniu1, S Montestruque, E J Bures, J Talvenheimo, R Toso, S Lewis-Sandy, A A Welcher, M F Rohde.   

Abstract

The extracellular domain of the human neurotrophin TRKB receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (BDNF). Two distinct ligand binding domains of TRKB were isolated from proteolytic digests of the receptor by affinity separation on immobilized BDNF. One of these domains consists of amino acid residues 103-181 and contains both the third leucine-rich motif and the second cysteine cluster domain. The second domain is close to the second immunoglobulin-like domain (amino acid residues 342-394). Each of these two domains can bind BDNF independently. Disulfide linkages present in the first domain are necessary for BDNF binding, probably because of preservation of the native conformation. To study the second domain in greater detail, a truncated form of TRKB containing the second immunoglobulin-like domain (residues 248-398) was expressed in Escherichia coli. This domain was cross-linked to BDNF through a 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide coupling reaction. Several synthetic peptides corresponding to amino acid residues 343-379 were able to bind immobilized BDNF. Amino acid substitution and cross-linking analysis indicated that amino acids Phe347, Asp354, and Tyr361 are intimately involved in BDNF binding. These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the TRKB receptor in binding BDNF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312147     DOI: 10.1074/jbc.272.40.25296

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Comparative insights using the molecular homology model of BDNF (Brain derived neurotrophic factor) of Varanus komodoensis and the known NGF (Nerve growth factor) structure of Naja atra.

Authors:  Ankit Verma; Dhirendra Kumar Sharma; Rituparna Sarma; Hasnahana Chetia; Juri Saikia
Journal:  Bioinformation       Date:  2013-08-28

2.  A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone.

Authors:  Sung-Wuk Jang; Xia Liu; Manuel Yepes; Kennie R Shepherd; Gary W Miller; Yang Liu; W David Wilson; Ge Xiao; Bruno Blanchi; Yi E Sun; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

3.  Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia.

Authors:  Rodolfo E Gámez Sazo; Katsumi Maenaka; Weiyong Gu; Patrick M Wood; Mary Bartlett Bunge
Journal:  Biomaterials       Date:  2012-08-17       Impact factor: 12.479

Review 4.  Novel small molecule activators of the Trk family of receptor tyrosine kinases.

Authors:  Obiamaka Obianyo; Keqiang Ye
Journal:  Biochim Biophys Acta       Date:  2012-09-06

Review 5.  Fibrinogen and Neuroinflammation During Traumatic Brain Injury.

Authors:  Nurul Sulimai; David Lominadze
Journal:  Mol Neurobiol       Date:  2020-08-10       Impact factor: 5.590

6.  Long-term potentiation promotes proliferation/survival and neuronal differentiation of neural stem/progenitor cells.

Authors:  Taesup Cho; Jae K Ryu; Changiz Taghibiglou; Yuan Ge; Allen W Chan; Lidong Liu; Jie Lu; James G McLarnon; Yu Tian Wang
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

Review 7.  α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis.

Authors:  Laura M Butkovich; Madelyn C Houser; Malú G Tansey
Journal:  Front Neurosci       Date:  2018-09-11       Impact factor: 4.677

8.  Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling.

Authors:  Andrew Osborne; Tasneem Z Khatib; Lalana Songra; Amanda C Barber; Katie Hall; George Y X Kong; Peter S Widdowson; Keith R Martin
Journal:  Cell Death Dis       Date:  2018-09-26       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.